INTRODUCTION
The nuclear matrix has been biochemically and morphologically defined as the chromatin-free, insoluble framework of the nucleus. Following the original discovery of the nuclear matrix [1, 2] , methods for separating it from chromatin have been undergoing continous development [3] [4] [5] [6] . A sequential extraction procedure has revealed an intermediate filament-like nuclear network termed 'the core filaments of the nuclear matrix' [6] . These filaments, resembling those described by Jackson and Cook [7] , may serve as the core structures around which the matrix is built. The matrix has been associated with a variety of nuclear processes including transcription [8, 9] , splicing [10] and replication [11, 12] . These processes have been localized in discrete nuclear domains rather than diffusely distributed throughout the nucleoplasm, persisting after the removal of chromatin. This suggests that the nuclear matrix plays an important role in maintaining spatial order within the nucleus. Despite many essential functions postulated for the nuclear matrix, few proteins involved in these processes have been characterized so far. Among these are the lamins A, B and C of the nuclear lamina [13] [14] [15] and several internal nuclear matrix proteins including topoisomerase II [16] , a calmodulin-stimulated protein kinase [17] and the nuclear-mitotic apparatus protein, NuMA [18, 19] . A more detailed study of nuclear matrix function will require the characterization of additional nuclear matrix proteins.
Protein 4.1 is a major component of the erythrocyte membrane skeleton that promotes the interaction of spectrin with actin and links the resulting complex network to integral membrane proteins. Although protein 4.1 was originally identified as an element of erythrocytes, its presence in many mammalian cell types is now well documented (reviewed in [20] ). The major protein 4 .1 isoforms in human erythrocytes are a doublet of Mr -78000 and 80000, but avian erythrocytes and mammalian Interestingly, nuclear matrices isolated after DNase I digestion and sequential treatments with increasing ionic strength contain a third 4.1 polypeptide of Mr -75000 (4.1p75), suggesting that it is a component of the nuclear matrix. Immunoblot analyses of nuclear matrices isolated from different cell types and species indicate that 4. 1p75 is a common element of the nuclear matrix of mammalian cells. Moreover, 4.lp75 distributes to typical nuclear speckles which are enriched with the spliceosome assembly factor SC35, as revealed by double-label immunofluorescence analyses. Protein 4.lp75 might be an anchoring element of the nucleoskeleton, playing a role similar to that described for the erythroid protein 4.1 in red blood cells.
non-erythroid tissues present a variety of immunoreactive 4.1 polypeptides of Mrs ranging from 30000 to 210000 [21, 22] . Posttranslational modifications such as phosphorylation by multiple kinases and glycosylation with 0-linked N-acetylglucosamine could partly account for the impressive diversity of 4.1 proteins (reviewed in [20] ). However, it is clear that multiple structural isoforms of 4.1 can be produced by alternative splicing of the transcript of a single gene both in erythroid and non-erythroid tissues [23] [24] [25] [26] [27] [28] . There are at least 10 motifs that can be selectively included or excluded from the mRNA transcript, in various combinations, to produce these isoforms [25, 29] . The functional role of non-erythroid 4.1 isoforms remains unknown. Interestingly, isolated erythroid 4.1 binds tubulin [30] and myosin [31] , suggesting that certain isoforms of protein 4.1 may play some role in integrating the membrane skeleton with the larger cytoskeleton. It has also been described that antibodies against protein 4.1 stain the mammalian nucleus in diffuse as well as in speckled-like patterns [32] Figure 1 Scheme of the nuclear matrix isolation methods
In method chromatin is removed by high-salt extraction followed by nuclease digestion which may induce shrinkage of the nucleus. The sequential extraction steps were carried out with Triton X-100, medium (0.5 M NaCI) and high (2 M NaCI) ionic strength, and DNase digestion; all solutions were prepared in PEM buffer (see the Materials and methods section). In method 11 chromatin is removed by nuclease digestion followed by extraction by a gradually increased ionic strength which greatly reduces the nuclear shrinkage [6] . The sequential extraction steps were carried out with Triton X-100, DNase digestion and a gradual increase in ionic strength; all solutions were prepared in CSK buffer. Figure 1 ).
Method
Cells were sequentially extracted with (a) 0.5 % Triton X-100 in PEM (100 mM Pipes, pH 6.2, 1 mM EGTA, 1 mM MgCl2) for 2 min at room temperature (RT); (b) 0.5 M NaCl in PEM for 5 min at RT; (c) 2 M NaCl in PEM for 5 min at RT; (d) RNasefree DNase I (100 ug/ml) in PEM for 30 min at 37°C and 0.25 M ammonium sulphate in PEM for 5 min at RT.
Method 11
Cells on coverslips were lysed for 2 min at RT in cytoskeletal (CSK) buffer (10 mM Pipes, pH 6.8, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 1 mM EGTA) containing 0.5 % Triton X-100, and then digested with 100 ,ug/ml of RNase-free DNase I in CSK buffer at RT for 30 min and extracted with 0.25 M ammonium sulphate in CSK buffer for 5 min at RT. Finally, the coverslips were immersed in CSK buffer and a similar volume of 4 M NaCl was added dropwise with gentle shaking to a final concentration of 2 M NaCl [6, 33] . This process removes the cytosolic soluble proteins, the chromatin and chromatinassociated proteins and the outer nuclear matrix proteins, leaving the nuclear lamina and the internal nuclear matrix [6, 34] . After each step, cells on coverslips were fixed and incubated with antibodies as indicated below. All buffers were prepared with a cocktail of protease inhibitors containing 1 ,ug/ml aprotinin, 1 jug/ml leupeptin, 1 ,tg/ml pepstatin and 1 mM PMSF.
Immunofluorescence microscopy Cells grown on glass coverslips were extracted by methods I or II (see Figure 1 ) and fixed in 10 % formalin (37 % formaldehyde solution, Sigma-F1635) for 15 min at RT. After fixation, cells were washed in PBS and blocked in PBS containing 3 % (w/v) BSA for 20 min. Cells were then incubated with affinity-purified polyclonal antibodies against the 8000-Mr domain of protein 4.1 involved in the association of4.1 with spectrin and actin [32, 35, 36] for 1 h at RT. Coverslips were rinsed in PBS and then incubated with secondary Texas Red-labelled goat anti-(rabbit IgG) antibodies for 45 min at RT. For double-labelling experiments, monoclonal anti-BIC8 [34] or anti-SC35 [37] antibodies (obtained from Dr. S. Penman and from the American Type Culture Collection, respectively) were added to the coverslips following the incubation step with the secondary anti-(rabbit IgG) antibodies and the reactions were visualized with fluorescein isothiocyanate (FITC)-conjugated goat anti-(mouse IgG) antibodies. After several washes in PBS, preparations were dried, mounted on microscope slides with Mowiol 40.88 and examined with a Zeiss epifluorescence microscope. In some experiments, chromatin was stained with 0.01 ,ug/ml Hoechst 33258 just before the preparations were mounted.
Analysis of cell fractions by immunoblotting
For electrophoresis and immunoblotting analysis, cells grown on Petri dishes were rinsed twice in PBS and then scraped with a rubber policeman. Method II (see Figure 1 ) has been followed with slight modifications. After the extraction of soluble proteins with 0.5 % Triton X-100, cells were resuspended in RSB buffer [10 mM Tris/HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 1 mM PMSF, 1 % (v/v) Nonidet P-40, and 0.5 % (v/v) sodium deoxycholate] for 15 min at 0°C with three periods of vortexing of 30 s each, and centrifuged at 500 g for 5 min at 4 'C. This step removes the cytoskeleton, leaving the nuclei with their attached intermediate filaments [6] . Most of the intermediate filament proteins were extracted by homogenizing the pellets in 3 mM imidazole, pH 7.4, [38] by ten passages through a 22G1 1/4-gauge needle fitted on a plastic syringe. The next extraction steps were the same as described in method II for in situ sequential extractions. Protein extracts from MDCK, HeLa, NIH 3T3, BHK, COS and A498 cells were precipitated in 7 % tri-chloroacetic acid, washed in cold ethanol, dried in a Speedvac microfuge, and finally resuspended in Laemmli buffer [39] . Proteins from each fraction were separated by SDS/PAGE in 8 % acrylamide minigels. Gels were stained with Coomassie Brilliant Blue R 250 or transferred to Immobilon-PVDF at 100 V for 75 min in 3-(cyclohexylamino)-l-propanesulphonic acid (CAPS) buffer, pH 11.
Immobilon membranes with transferred proteins were blocked with 10% (w/v) dry milk containing 0.05 % Tween 20 in PBS overnight at 4 
RESULTS
Previous studies from our laboratory showed that antibodies against protein 4.1 stained the nucleus of mammalian cells showing a speckle-like pattern, leaving the nucleolus unstained [32] . Since this immunofluorescence staining pattern appears to be characteristic of many nuclear matrix proteins, we have used these characterized antibodies [32, 36] to determine whether or not protein 4.1 is a component of the nuclear matrix of mammalian cells.
Localization of protein 4.1 in the nuclear matrix by immunofluorescence microscopy Two different methods have been used to prepare nuclear matrices in situ. In the first one ( Figure 1 , method I), chromatin is removed by exposure to high salt concentrations (2 M NaCl) followed by nuclease digestion, as most earlier preparations have been performed [1, [40] [41] [42] . Cells extracted with Triton X-100 and labelled with antibodies to protein 4.1 show diffuse cytoplasmic staining as well as diffuse nuclear staining distributed throughout the nucleoplasm and staining of discrete foci or speckles ( Figure  2a) . Nucleoli remain unstained, appearing as globular units outlined by the diffusely stained surrounding nucleoplasm. Cells treated with 0.5 M NaCl present the nuclear-speckled staining pattern, more evident because of a reduction in the diffuse nucleoplasmic staining (Figure 2b ). This suggests that protein 4.1 diffusely distributed in the nucleoplasm is removed by this ionic strength step, whereas the protein 4.1 responsible for the speckled staining remains after the treatment. Bright speckles are still observed throughout the nuclei following the removal of chromatin by 2 M NaCl treatment (Figure 2c ) and DNase I digestion (Figure 2d) . Thus, the persistence of the speckled staining at the last step of nuclear matrix preparation suggests that protein 4.1 is a component of the nuclear matrix.
A more recent method has been developed which preserves the morphology of the nuclear matrix without submitting it to a great degree of shrinkage [6] . In this method (method II, Figure  1 ), chromatin is removed by digesting nuclei with DNase I followed by elution of chromatin with a low ionic strength (0.25 M ammonium sulphate). This treatment leaves the complete nuclear matrix still connected to the intermediate filaments of the cytoskeleton [6, 43] . Further extraction with 2 M NaCl removes most of the outer proteins of the nuclear matrix, leaving the nuclear lamina and the internal nuclear matrix. When chromatin is removed by DNase I digestion and lowionic-strength extraction (observe the lack of DNA staining with Hoechst 33258 in Figure 3b and compare with its presence in Figure 3a ), a speckled immunofluorescent staining pattern is observed for protein 4.1 in the nuclear matrix preparations ( Figure 3B ). The diffuse nucleoplasmic immunofluorescent staining observed in cells extracted with Triton X-100 ( Figure 3A ) was highly reduced (compare Figures 3A and 3B) . The speckle-like immunofluorescent staining persists after extensive extractions of cells in solutions of 2 M ionic strength ( Figure 3C ), indicating that protein 4.1 is a component of the nucleoskeleton.
immunoblotting analyses of subcelluiar fractions Multiple tissue-specific isoforms ofprotein 4.1, ranging in relative molecular masses from -30000 to 210-000, have been described [21] ; however, neither their distribution nor their cellular role is yet known. To learn more about the location of protein 4.1 within the nucleus, we have tried to correlate the observed immunofluorescent staining patterns with immunoblots of equivalent amounts of protein extracts and of nuclear matrices prepared from MDCK cells by method II. To extract the cytoskeletal framework of MDCK cells, two additional steps were included after Triton X-l00 treatment. The RSB buffer used for the extraction of cytoskeletal proteins from the majority of cell lines [6, 43] is not sufficient to remove the cytoskeletal proteins of MDCK cells, which are mostly removed, however, in 3 mM imidazole. This is illustrated in Figure 4 (a), which shows the Coomassie Blue staining patterns of protein extracts obtained at different steps of the purifications as well as that in the final pellet corresponding to the nuclear matrix. The lamins are observed in the pellet fraction. Figure 4(b) shows the immunoblot analysis of the fractions analysed in Figure 4 (a). Total homogenates of MDCK contain several 4.1-immunoreactive bands, the major ones of Mr -50000, 80000, 100000 and 135000 (designated 4.lp5O, 4.lp8O, 4.1plOO and 4.lpl35 respectively). Proteins of similar relative molecular masses have been detected in other cell lines [21, 27, 28, 32] . Several 4.1-immunoreactive bands are extracted at different steps of the nuclear matrix isolation procedure. Triton X-100 treatment, which removes soluble proteins leaving the cytoskeleton framework and associated proteins attached to the remnants, resulted in the extraction of some 4. 1-immunoreactive proteins (4. ip5O, 4. lp8O and 4. lplOO).
The cytoskeleton extraction buffer, RSB, removes a small amount of 4.lp8O and some of 4.ip5o, whereas imidazole extracts are enriched in 4.1p5O. These results suggest that 4.1p8O and 4.1p5O may be associated with the cytoskeletal network. Indeed, the association of protein 4.1 with spectrin and actin [441 through its 8000-Mr domain [35, 36] and with tubulin [30] Figure 4 Immunoblot analyses of MDCK fractions prepared by method 11
Proteins were separated by SDS/PAGE (8% acrylamide) and the resulting gels were either stained by Coomassie Blue (a) or transferred to Immobilon-PVDF and incubated with affinitypurified polyclonal antibodies to 4.1. (b) Key to lanes: porcine red blood cell ghost proteins (GHOST), MDCK total extract proteins (TOTAL), soluble proteins extracted with 0.5% Triton X-100 (TX1 00), cytoskeletal proteins extracted with RSB buffer containing 1 % Nonidet P-40 and 0.5% sodium deoxycholate (RSB), cytoskeletal proteins, enriched in intermediate filaments, extracted with 3 mM imidazole (3 mM IMIDAZ), chromatin and chromatin-associated proteins extracted with 100 jug/ml RNase-free DNase (DNase I) and with 0.25 M ammonium sulphate (0.25 M A.S.), outer nuclear matrix proteins extracted with 2 M NaCI (2 M NaCI), and nuclear matrix fraction that remains after the complete extraction in CSK buffer (PELLET). Figure 5 shows the immunoblot analyses of nuclear matrix preparations from HeLa cells. Indeed, extraction of chromatin is accompanied by the removal of 4.1pl75 and 4.1pl35 proteins, whereas a 4.1p75 protein remains in the nuclear matrix pellet. These results suggest that 4.1pl35 and 4.1pl75 may be associated with chromatin and that 4.1p75 may be a component of the nuclear matrix common to different mammalian cells. Protein 4.1p75 is a common component of the nuclear matrix of mammalian cells Electrophoretic analyses have shown that the nuclear matrix is composed of a complex set of proteins, some of which are celltype specific whereas others appear to be ubiquitous [46, 47] . To determine whether 4.1p75 is cell-type specific or not, we have prepared nuclear matrices from different cell lines (Figure 6) MDCK cells sequentially extracted by method 11 to produce nuclear matrices were doubleimmunostained with affinity-purified polyclonal antibodies to 4.1 (a and c) and with anti-BlC8 monoclonal antibodies (b) or with anti-SC35 monoclonal antibodies (d). These data suggest that 4.1 p75 concentrates to nuclear speckles enriched with splicing proteins. Bar represents 3 ,um. nuclear speckles that also contain the nuclear matrix antigen B1C8 (Figures 7a and 7b, respectively) . Splicing proteins accumulate in typical nuclear speckle domains (reviewed in [48] ). To analyse whether or not the nuclear speckles containing 4.1p75 are enriched with splicing proteins, we have carried out double-label immunofluorescence studies. A monoclonal antibody against the non-small nuclear ribonucleoprotein particle (snRNP) splicing factor SC35 [37] has been used to detect nuclear speckle domains enriched with splicing factors. Figure 7(c) shows the distribution of 4. 1p75 in nuclear matrices prepared from MDCK cells and Figure 7( [27, 32] which appeared to be a moderately bound element of the nuclear matrix [45] . Bands of lower M, that share antigenic determinants with erythrocyte protein 4.1 are also observed. Some of the lower-M, bands could be proteolytic artifacts despite the use of protease inhibitors at all stages of sample preparation, but it is also possible that they exist as such within the cell, since 4.1 polypeptides of Mrs ranging from 30000 to 210000 have been described [21] .
Most nuclear proteins contain short amino acid sequences, known as nuclear localization signals (NLSs), which mediate their import to the nucleus [49] [50] [51] . Protein 4.1 sequence contains two putative NLSs that fit the NLS consensus sequence, K-K/R-X-K/R, proposed by Chelsky and co-workers [52] . One putative NLS sequence, KRPK, would be encoded by exon 2; the second one, KKKR, would be generated by joining exon 13 and 16 sequences as a result of eliminating exons 14 and 15 by alternative splicing. Interestingly, a similar alternative splicing event has been described to generate the NLS sequence, KKRK, that targets multifunctional Ca2+/calmodulin-dependent protein kinase to the nucleus [53] . The amino acid sequence responsible for the import of protein 4.1 to the nucleus remains to be established.
Pre-mRNA splicing factors are enriched in at least two distinct types of nuclear structures: 'speckles', which exist at the level of 20-50 per mammalian cell nucleus (reviewed in [48] ) and 'coiled bodies', which exist at the level of one to five (reviewed in [54] ). These structures are retained in nuclear matrix preparations [55] [56] [57] [58] and there is evidence that splicing occurs in association with the nuclear matrix [10, [59] [60] [61] , thus indicating that some elements of the nucleoskeleton are anchoring splicing factors either directly or indirectly. Our results show that 4. lp75 distributes in irregularly shaped speckles also containing B1C8 antigen, a nuclear matrix protein involved in pre-mRNA processing [34, 62] and the non-snRNP splicing factor SC35 [37] .
Interestingly, the distribution of 4.1p75 in irregularly shaped speckle domains in transcriptionally active cells is modified during states of transcriptional inhibition (results not shown) in a similar way as for the splicing factor SC35 [63] .
The role that 4.1p75 may be playing as an element of the nuclear matrix is intriguing. The presence of both actin [64, 65] and spectrin [40] in the nucleus has been reported, therefore it is possible that a protein meshwork similar to that found in the membrane skeleton could constitute part of the scaffolding to which splicing factors and/or other nuclear matrix proteins may bind. Whether 4.1p75 is playing a structural role as protein 4.1 does in the red blood cell, or is directly involved in pre-mRNA processing as are other nuclear matrix proteins, remains to be elucidated.
